News

Medical Device Company INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for INVOcell, its Infertility Solution

INVO Bioscience, a medical device company focused on commercializing the world’s only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, is pleased to announce the appointment of tenured women’s health & fertility solution marketing professional, Meryle Lynn Chamberlain, as Director of Marketing, a newly created position within the company. Chamberlain brings over 15 years of…

MDVIP & Ipsos Release New Study on Women’s Health Literacy Drawing Attention to Gaps in Women’s Health Knowledge and Healthcare Experiences

Although women make the lion’s share of healthcare decisions in the U.S., most are in the dark when it comes to their own health, according to a new survey on women’s health from MDVIP and Ipsos. A staggering 94 percent of women across all ages 20 and up failed a Women’s Health IQ Quiz, revealing their vast lack of knowledge about the health…

Orchyd Launches a New Period Tracker and Bluetooth-Enabled Smart Wallet

Orchyd is launching a new period-tracking app and Bluetooth-enabled connected smart wallet that together that stores a one-day supply of period care products. The company was founded by sisters Courtney and Morgan King. “We set out to build a better menstrual experience by combining an advanced health app, wellness tracker, geo-location technology, and access to an affordable OB/GYN that is open to everyone, anywhere,” said Morgan…

Event: Women 40+ Innovation Summit

In 2021 the team behind Women’s Health Innovation Summit is organizing a series of events leading up to its signature event in the fall. The second event in this series, the Women 40+ Innovation Summit will take place virtually on June 22 & 23. Whilst there has been an improved focus on Women’s Health and Femtech Innovations, the industry has yet to extend its innovative arm…

Alife Health raises a $9M Seed Round to Improve IVF Outcomes

1 in 8 families now struggle with infertility. Studies show that the average healthy couple has a 20 percent natural fertility rate per cycle, and miscarriages in women are increasing by about 1 percent each year. Additionally, Black and Latinx women are less likely to access fertility care and have a successful IVF pregnancy. As fertility continues to be in crisis, new artificial…

electronRx Receives a Grant from Innovate UK for ‘Ohmm’, its Novel Wearable Period Pain Relief Technology

Innovate UK, the UK’s innovation agency, has awarded a Smart Grant to deep tech startup electronRx to support the development of their novel period pain relief technology, Ohmm. The discreet wearable device administers their proprietary neuromuscular electrical stimulation to neutralize the two main causes of menstrual pain, uterine cramps and inflammation, providing drug-free, long-lasting relief.  electronRx CEO and Founder, Dr. Bipin Patel,…

LiquidGoldConcept Receives an NIH Grant for Further Commercialization of its Lactation Support Training Technology

U.S. based femtech startup LiquidGoldConcept announced it has been awarded an additional $55,000 in National Institutes of Health (NIH) funding in support of its Lactation Simulation Models (LSM) and Newborn Oral Assessment and Latch Simulators (NORALSim). The new grant is in addition to $250,000 in NIH support the company received in July of 2020 for its breastfeeding training technology. The $55,000 grant is through the National Centers for Clinical and Translational Science (NCATS), a…

Women’s Reproductive Health Pharma Company ObsEva Appoints Clive Bertram as Chief Commercial Officer

ObsEva, a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the appointment of Clive Bertram as Chief Commercial Officer and member of ObsEva’s Executive Committee, effective May 10, 2021. Wim Souverijns has served as Chief Commercial Officer of ObsEva since November 2018 and will leave the Company on June 30, 2021 to pursue a new opportunity.…